title: Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma.
abstract: BACKGROUND
  Involved field radiation therapy (IFRT) is integral in curative therapy for Hodgkin lymphoma (HL), although primarily used in patients with intermediate/high-risk HL. We present failure patterns and clinical outcomes in a cohort of pediatric and young adult patients with HL treated with IFRT at the Johns Hopkins Hospital.
  
  
  METHODS
  Patients ≤40 years old with intermediate/high-risk HL who received chemotherapy and IFRT from 1997 to 2012 were included in this retrospective analysis. Patients were evaluated for failure patterns, overall survival (OS), and event-free survival (EFS) using Kaplan-Meier curves, descriptive statistics, and Cox proportional hazard regressions.
  
  
  RESULTS
  We reviewed 74 patients (45 pediatric and 29 young adult) with a median follow-up of 4.4 years. The mean age at diagnosis was 21.4 years. Patients received a median of 29.75 Gy of IFRT (range 15-39.6 Gy). The majority of pediatric patients received ABVE-PC chemotherapy (n = 25) and <30 Gy of radiation (n = 33) while most young adults received ABVD chemotherapy (n = 24) and ≥30 Gy (n = 25). Estimated 5-year OS and EFS were 96% and 81%, respectively. Thirteen patients had recurrence; eight were pediatric. Distant relapse alone comprised 83% of failures in patients receiving ≥30 Gy. Of the seven patients who received <30 Gy and had recurrence, six had local failure as a component of their recurrence. Caucasian race (P = 0.02) and nodular sclerosing histology (P = 0.01) predicted for increased EFS. Late effects were minimal and all deaths (n = 4) were from HL.
  
  
  CONCLUSIONS
  In this series, pediatric and young adult patients were treated with differing chemoradiation and had distinct recurrence patterns.
authors: Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors: Minh-Phuong
authors: MP
authors: Huynh-Le
authors: Amanda J
authors: AJ
authors: Walker
authors: Scott Duke
authors: SD
authors: Kominers
authors: Ido
authors: I
authors: Paz-Priel
authors: Moody D
authors: MD
authors: Wharam
authors: Stephanie A
authors: SA
authors: Terezakis
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D059248:Chemoradiotherapy; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
keywords: Hodgkin lymphoma; hematology/oncology; involved field radiation therapy